|
|
GovernmentDocs 5/5/2008 | 0 (0) | 75 | 3 | 0 | English
FDA Electronic Submissions Gateway (ESG)User Guide November 20, 2007Table Of Contents1 Introduction ... more>>
GovernmentDocs 5/5/2008 | 0 (0) | 73 | 1 | 0 | English
FDA MEDIA TELECONFERENCE FOOD AND DRUG ADMINISTRATION AMENDMENTS ACT OF 2007 Sept. 27, 2007, 2 p.m. EDT Coordinator: Welcome and thank you for standing by. At this time all parties are in a ... more>>
FDADocs 5/9/2008 | 0 (0) | 71 | 1 | 0 | English
DOCUMENT INFORMATION PAGEThis page is for FDA internal use only. Do NOT send this page with the... revisions listed in the letter. SNDA-H4 AE RT/October 11, 2005C:\Documents and Settings\TAYLORR ... more>>
GovernmentDocs 5/4/2008 | 0 (0) | 70 | 0 | 0 | English
Guidance for Industry and FDA Staff FDA and Industry Actions on Premarket Approval Applications (PMAs): Effect on FDA Review Clock and Performance AssessmentDocument Issued on: October 8, 2003For ... more>>
FDADocs 5/9/2008 | 0 (0) | 70 | 0 | 0 | English
FDA Approved Labeling Text for NDA 21-717/S-005 & S-008 FINAL-Label-23-JAN-2004 PROVIGIL?? (modafinil) Tablets [C-IV] DESCRIPTION PROVIGIL (modafinil) is a wakefulness-promoting agent for oral ... more>>
GovernmentDocs 5/5/2008 | 0 (0) | 68 | 1 | 0 | English
DEPARTMENT OF HEALTH & HUMAN SERVICESPublic Health ServiceFood and Drug Administration Rockville, MD 20857NDA 18-662/S046Hoffman-La Roche Inc. Attention: Joanna Wau... ... more>>
FDADocs 5/9/2008 | 0 (0) | 67 | 1 | 0 | English
Evaluation of Biotechnology-Derived Pharmaceuticals (July 1997) (http://www.fda.gov/cder/guidance ... more>>
FDADocs 5/9/2008 | 0 (0) | 66 | 0 | 0 | English
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health ServiceDivision of Dermatologic and Dental Drug Products Office of Drug Evaluation V Center for Drug Evaluation and Research F... ... more>>
FDADocs 5/9/2008 | 0 (0) | 63 | 0 | 0 | English
DISTRICT ADDRESS AND PHONE NO.DEPARTMENT OF HEALTH AND HUMAN SERVICESFOOD AND DRUG ADMINISTRATIONNAME AND TITLE OF INDIVIDUAL300 S. Riverside Plaza, Suite 550 South Chi... ... more>>
FDADocs 5/9/2008 | 0 (0) | 62 | 1 | 0 | English
Script - An Introduction to the Improved FDA Prescription Drug LabelingWelcome and thank you for participating in the Food and Drug Administration, Center for Drug Evaluation and Research ... more>>
FDADocs 5/9/2008 | 0 (0) | 61 | 1 | 0 | English
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health ServiceDivision of Dermatologic and Dental Drug Products Office of Drug Evaluation III Center for Drug Evaluation and Research... ... more>>
FDADocs 5/9/2008 | 0 (0) | 61 | 0 | 0 | English
FDA Forum handheld Doppler safetyPage 1FDA Forum handheld Doppler safetyPage 2FDA Forum handheld Doppler safetyPage 3FDA Forum handheld Doppler safetyPage 4FDA ... more>>
FDADocs 5/5/2008 | 0 (0) | 61 | 1 | 0 | English
FDA Regulations and Recommendations for Failure InvestigationsHoi-may Wong, BS, MT(ACSP)SBB Blood and Plasma Branch Division of Blood Applications, FDA, CBER, OBRRFDA Workshop Licensure of ... more>>
GovernmentDocs 5/4/2008 | 0 (0) | 61 | 0 | 0 | English
Center For Drug Evaluation and Research List of Guidance DocumentsGuidance documents represent... or on any person and do not operate to bind FDA or the public. An alternative approach may be used if ... more>>
GovernmentDocs 5/5/2008 | 0 (0) | 61 | 0 | 0 | English
NDA 20-895/S-003Pfizer Inc Attention: Rita Wittich Director, Regulatory Affairs 235 East 42nd Street New York, NY 10017Dear Ms. Wittich: Please refer to your supplemental n... ... more>>
| | | |
| results / page 15/25/50 |
Page: 3 of 33
|
3...
|
|